Robert L. Rosiello

2015

In 2015, Robert L. Rosiello earned a total compensation of $60.4M as Executive Vice President and Chief Financial Officer at Valeant Pharmaceuticals International.

Compensation breakdown

Bonus$6,000,000
Non-Equity Incentive Plan$712,184
Salary$546,154
Stock Awards$53,126,290
Other$13,770
Total$60,398,398

Rosiello received $53.1M in stock awards, accounting for 88% of the total pay in 2015.

Rosiello also received $6M in bonus, $712.2K in non-equity incentive plan, $546.2K in salary and $13.8K in other compensation.

Rankings

In 2015, Robert L. Rosiello's compensation ranked 9th out of 13,638 executives tracked by ExecPay. In other words, Rosiello earned more than 99.9% of executives.

ClassificationRankingPercentile
All
9
out of 13,638
100th
Division
Manufacturing
5
out of 5,190
100th
Major group
Chemicals And Allied Products
4
out of 1,854
100th
Industry group
Drugs
4
out of 1,528
100th
Industry
Pharmaceutical Preparations
3
out of 1,182
100th
Source: SEC filing on April 29, 2016.

Rosiello's colleagues

We found six more compensation records of executives who worked with Robert L. Rosiello at Valeant Pharmaceuticals International in 2015.

2015

J Pearson

Valeant Pharmaceuticals International

Chief Executive Officer

2015

Anne Whitaker

Valeant Pharmaceuticals International

Group Chairman

2015

Brian Stolz

Valeant Pharmaceuticals International

Senior Vice President and General Manager

2015

Debora Jorn

Valeant Pharmaceuticals International

Group Chairman

2015

Ari Kellen

Valeant Pharmaceuticals International

Group Chairman

2015

Howard Schiller

Valeant Pharmaceuticals International

Chief Financial Officer

You may also like